Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 10(1): 19617, 2020 11 12.
Artículo en Inglés | MEDLINE | ID: mdl-33184378

RESUMEN

Melanoma is the most aggressive and fatal type of skin cancer due to being highly proliferative. Acetylsalicylic acid (ASA; Aspirin) and salicylic acid (SA) are ancient drugs with multiple applications in medicine. Here, we showed that ASA and SA present anticancer effects against a murine model of implanted melanoma. These effects were also validated in 3D- and 2D-cultured melanoma B16F10 cells, where the drugs promoted pro-apoptotic effects. In both in vivo and in vitro models, SA and ASA triggered endoplasmic reticulum (ER) stress, which culminates with the upregulation of the pro-apoptotic transcription factor C/EBP homologous protein (CHOP). These effects are initiated by ASA/SA-triggered Akt/mTOR/AMPK-dependent activation of nitric oxide synthase 3 (eNOS), which increases nitric oxide and reactive oxygen species production inducing ER stress response. In the end, we propose that ASA and SA instigate anticancer effects by a novel mechanism, the activation of ER stress.


Asunto(s)
Apoptosis/efectos de los fármacos , Aspirina/farmacología , Estrés del Retículo Endoplásmico/efectos de los fármacos , Melanoma/etiología , Melanoma/patología , Óxido Nítrico/metabolismo , Ácido Salicílico/farmacología , Neoplasias Cutáneas/etiología , Neoplasias Cutáneas/patología , Proteínas Quinasas Activadas por AMP/metabolismo , Animales , Antineoplásicos , Aspirina/uso terapéutico , Línea Celular Tumoral , Modelos Animales de Enfermedad , Masculino , Melanoma/tratamiento farmacológico , Ratones Endogámicos C57BL , Terapia Molecular Dirigida , Óxido Nítrico Sintasa de Tipo III/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ácido Salicílico/uso terapéutico , Neoplasias Cutáneas/tratamiento farmacológico , Serina-Treonina Quinasas TOR/metabolismo , Regulación hacia Arriba/efectos de los fármacos
2.
Free Radic Biol Med ; 108: 183-191, 2017 07.
Artículo en Inglés | MEDLINE | ID: mdl-28363600

RESUMEN

Trypanosoma cruzi is the causative agent of Chagas disease and has a single mitochondrion, an organelle responsible for ATP production and the main site for the formation of reactive oxygen species (ROS). T. cruzi is an obligate intracellular parasite with a complex life cycle that alternates between vertebrate and invertebrate hosts, therefore the development of survival strategies and morphogenetic adaptations to deal with the various environments is mandatory. Over the years our group has been studying the vector-parasite interactions using heme as a physiological oxidant molecule that triggered epimastigote proliferation however, the source of ROS induced by heme remained unknown. In the present study we demonstrate the involvement of heme in the parasite mitochondrial metabolism, decreasing oxygen consumption leading to increased mitochondrial ROS and membrane potential. First, we incubated epimastigotes with carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP), an uncoupler of oxidative phosphorylation, which led to decreased ROS formation and parasite proliferation, even in the presence of heme, correlating mitochondrial ROS and T. cruzi survival. This hypothesis was confirmed after the mitochondria-targeted antioxidant ((2-(2,2,6,6 Tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl) triphenylphosphonium chloride (MitoTEMPO) decreased both heme-induced ROS and epimastigote proliferation. Furthermore, heme increased the percentage of tetramethylrhodamine methyl ester (TMRM) positive parasites tremendously-indicating the hyperpolarization and increase of potential of the mitochondrial membrane (ΔΨm). Assessing the mitochondrial functional metabolism, we observed that in comparison to untreated parasites, heme-treated epimastigotes decreased their oxygen consumption, and increased the complex II-III activity. These changes allowed the electron flow into the electron transport system, even though the complex IV (cytochrome c oxidase) activity decreased significantly, showing that heme-induced mitochondrial ROS appears to be a consequence of the enhanced mitochondrial physiological modulation. Finally, the parasites that were submitted to high concentrations of heme presented no alterations in the ultrastructure. Consequently, our results suggest that heme released by the insect vector after the blood meal, modify epimastigote mitochondrial physiology to increase ROS as a metabolic mechanism to maintain epimastigote survival and proliferation.


Asunto(s)
Enfermedad de Chagas/inmunología , Hemo/metabolismo , Mitocondrias/metabolismo , Trypanosoma cruzi/fisiología , Animales , Carbonil Cianuro p-Trifluorometoxifenil Hidrazona/metabolismo , Procesos de Crecimiento Celular , Células Cultivadas , Transporte de Electrón , Complejo IV de Transporte de Electrones/metabolismo , Metabolismo Energético , Humanos , Estadios del Ciclo de Vida , Potencial de la Membrana Mitocondrial , Compuestos Organofosforados/metabolismo , Consumo de Oxígeno , Piperidinas/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Rodaminas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...